UPDATE : Monday, February 17, 2020
If Invossa license gets revoked, Kolon should return $13 million to Mundipharma by Jeong Sae-im 2019-05-08 15:33
Mobile healthcare firm Noom raises $58 million for biz expansion by Jeong Sae-im 2019-05-08 15:23
Inspection will clear all suspicions over Invossa: TissueGene by Jeong Sae-im 2019-05-08 14:32
Kolon might have covered up Invossa mislabeling for 2 years by Jeong Sae-im 2019-05-07 15:55
[Exclusive] MSD workers appalled by executive’s remarks on childcare leave by Jeong Sae-im 2019-05-07 12:08
Civic group files complaint against Kolon, regulator by Jeong Sae-im 2019-04-30 14:59
Techniques for biobetters get ever more advanced by Jeong Sae-im 2019-04-29 11:48
‘Invossa scandal might be more far-reaching’ by Jeong Sae-im 2019-04-26 18:08
Foreign patients to join class-action suit against Kolon for Invossa by Jeong Sae-im 2019-04-25 15:39
Samsung Biologics logs ₩23.4 billion operating loss in Q1 by Jeong Sae-im 2019-04-25 12:08
Regulator suspends Eutilex’ trial on cell therapy by Jeong Sae-im 2019-04-23 15:13
Gene therapies’ potentials, challenges explained by Jeong Sae-im 2019-04-22 11:46
Why is TissueGene CEO silent about Invossa mislabeling? by Jeong Sae-im 2019-04-19 14:37
CJ HealthCare’s new gastric acid blocker K-Cab sold ₩ 1.5 billion in March by Jeong Sae-im 2019-04-18 15:27
Patients to file class-action suit against Kolon over Invossa by Jeong Sae-im 2019-04-17 14:58
‘Invossa lacked clinical evidence to be commercialized’ by Jeong Sae-im 2019-04-17 12:45
‘Kolon might have fabricated data to get Invossa approval’ by Jeong Sae-im 2019-04-16 11:07
All Invossa products contained 293 cells, Kolon confirms by Jeong Sae-im 2019-04-15 11:31
Invossa license won’t be revoked: Kolon CEO by Jeong Sae-im 2019-04-12 11:40
Regulator, Kolon rebuked for slow response to Invossa problem by Jeong Sae-im 2019-04-11 14:46
Back to Top